empty

Competition Law

6 results found for: competition law

Pharma director disqualified for breaking competition law

A director of a pharmaceutical manufacturer has been barred from holding a directorship at any UK company after admitting to his role in two separate anticompetitive agreements.

Change laws to stop pharma ‘pay for delay’ deals say economists

Systemic change is needed to stop pharmaceutical companies paying off rivals to keep cheaper generic drugs out of the market, UEA academics have warned.

EU court rules on GSK 'pay-for-delay' appeal

The European Court of Justice has upheld a UK decision that GSK and other companies entered an illegal agreement.

Drug firm coughs up £8m to competition watchdog in UK first

A pharmaceutical company has offered to pay the NHS £8m following an investigation into suspected collusion.

Drug companies “carved up the market” alleges watchdog

AMCo, Morningside and Alliance Healthcare have been accused of illegal market sharing over nitrofurantoin.

Pharma companies accused of breaking competition law

Four pharmaceutical companies have provisionally been found to have broken competition law.



This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.